Literature DB >> 19764409

Case of ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland.

Mitsuaki Ishida1, Machiko Hotta, Ryoji Kushima, Souichirou Tsuruoka, Masahito Ohji, Hidetoshi Okabe.   

Abstract

Ductal adenocarcinoma of the lacrimal gland is extremely rare; to our knowledge, only seven de novo cases and one case of ductal adenocarcinoma ex pleomorphic adenoma have been reported in the literature. Here, we report a case of ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland. A 70-year-old Japanese female received the resection of the recurrent lacrimal gland tumor (second surgery), under the clinical diagnosis of recurrent pleomorphic adenoma, fifteen years after the initial surgical resection. The resected tumor was composed of recurrent pleomorphic adenoma and adenocarcinoma. Adenocarcinoma component showed infiltrative papillo-tubular or microcystic growth of carcinoma cells, which had pleomorphic large nuclei with prominent nucleoli and rich eosinophilic cytoplasm. Large dilated ducts with central comedonecrosis were observed. Accordingly, the diagnosis of ductal adenocarcinoma ex pleomorphic adenoma was made. The tumor recurred locally eight months after the second surgery, and tumor exenteration was performed(third surgery). The histopathological features of the third surgical specimen were as same as those of the second surgical specimen. In the previously reported eight cases and the present case of lacrimal ductal adenocarcinomas, recurrence took place in 5 cases and two patients died from multiple metastases. These data suggests that lacrimal ductal adenocarcinoma appears to have a poor prognosis, similar to salivary duct carcinoma, which is one of the most aggressive salivary carcinoma. And further study is needed to clarify the clinicopathological features of the lacrimal ductal adenocarcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19764409

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  6 in total

Review 1.  Primary ductal adenocarcinoma of the lacrimal sac: the first reported case.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hideaki Kohzaki; Masahiko Arikata; Takeshi Shimizu; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 2.  Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature.

Authors:  Toshinobu Kubota; Suzuko Moritani; Shu Ichihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-24       Impact factor: 3.117

Review 3.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

4.  GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.

Authors:  Miao-Miao Zhu; Hong-Guang Cui; Xiao-Dong Teng
Journal:  Onco Targets Ther       Date:  2015-05-11       Impact factor: 4.147

5.  Androgen receptor-positive ductal adenocarcinoma of the nasolacrimal duct: A case report.

Authors:  In Ah Park; Ho-Seok Sa; Yoo-Sam Chung; Kyung-Ja Cho
Journal:  Am J Ophthalmol Case Rep       Date:  2016-11-14

6.  Primary ductal adenocarcinoma of lacrimal gland: Two case reports and review of the literature.

Authors:  Hsin-Yu Yang; Cheng-Hsien Wu; Chieh-Chih Tsai; Wei-Kuang Yu; Shu-Ching Kao; Catherine Jui-Ling Liu
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.